These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38613331)

  • 41. Specific legislation on biobanks in Spain.
    García-Merino IM; Consuegra I; Jiménez JL; Muñoz-Fernández MÁ
    Biopreserv Biobank; 2015 Jun; 13(3):207-11. PubMed ID: 26035011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Public perceptions of biobanks in China: a focus group study.
    Chen H; Gottweis H; Starkbaum J
    Biopreserv Biobank; 2013 Oct; 11(5):267-71. PubMed ID: 24835257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The necessity of broad consent and complementary regulations for the protection of personal data in biobanks: what can we learn from the German case?
    Taupitz J; Weigel J
    Public Health Genomics; 2012; 15(5):263-71. PubMed ID: 22722690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "It's all about trust": reflections of researchers on the complexity and controversy surrounding biobanking in South Africa.
    Moodley K; Singh S
    BMC Med Ethics; 2016 Oct; 17(1):57. PubMed ID: 27724893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Introduction to Starting a Biobank.
    Harati MD; Williams RR; Movassaghi M; Hojat A; Lucey GM; Yong WH
    Methods Mol Biol; 2019; 1897():7-16. PubMed ID: 30539430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Informed Consent in the Newly Established Biobank.
    Kinkorová J; Topolčan O; Kučera R
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31623267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Basic principles of biobanking: from biological samples to precision medicine for patients.
    Annaratone L; De Palma G; Bonizzi G; Sapino A; Botti G; Berrino E; Mannelli C; Arcella P; Di Martino S; Steffan A; Daidone MG; Canzonieri V; Parodi B; Paradiso AV; Barberis M; Marchiò C;
    Virchows Arch; 2021 Aug; 479(2):233-246. PubMed ID: 34255145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spanish Regulation of Biobanks.
    Nicolás P
    J Law Med Ethics; 2015; 43(4):801-15. PubMed ID: 26711419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biobanks and their importance in the clinical and scientific fields related to Spanish biomedical research.
    Doménech García N; Cal Purriños N
    Reumatol Clin; 2014; 10(5):304-8. PubMed ID: 24880921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development of Biobank Network in Japan].
    Ogishima S
    Gan To Kagaku Ryoho; 2022 Feb; 49(2):125-128. PubMed ID: 35249043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GBA/GBN-position on the feedback of incidental findings in biobank-based research: consensus-based workflow for hospital-based biobanks.
    Geiger J; Fuchs J; Starke M; Neumann M; Baber R; Nussbeck SY; Kiehntopf M; Specht C; Illig T; Hummel M; Jahns R
    Eur J Hum Genet; 2023 Sep; 31(9):1066-1072. PubMed ID: 36732662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patients' Knowledge and Attitude Toward Biobanks in Eastern Morocco.
    Lhousni S; Daoudi F; Belmokhtar I; Belmokhtar KY; Abda N; Boulouiz R; Tajir M; Bellaoui M; Ouarzane M
    Biopreserv Biobank; 2020 Jun; 18(3):189-195. PubMed ID: 32207985
    [No Abstract]   [Full Text] [Related]  

  • 54. Regulation of Biobanks in France.
    Rial-Sebbag E; Pigeon A
    J Law Med Ethics; 2015; 43(4):754-65. PubMed ID: 26711415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brazilian guidelines for biorepositories and biobanks of human biological material.
    Marodin G; Salgueiro JB; Motta Mda L; Santos LM
    Rev Assoc Med Bras (1992); 2013; 59(1):72-7. PubMed ID: 23440145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Access Governance for Biobanks: The Case of the BioSHaRE-EU Cohorts.
    Kaye J; Briceño Moraia L; Mitchell C; Bell J; Bovenberg JA; Tassé AM; Knoppers BM
    Biopreserv Biobank; 2016 Jun; 14(3):201-6. PubMed ID: 27183185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vignettes to Illustrate the Value of Tumor Biobanks in Cancer Research in Canada.
    Tarling T; Matzke LAM; Rush A; Gali B; Byrne JA; Watson PH
    Biopreserv Biobank; 2022 Feb; 20(1):75-83. PubMed ID: 34165356
    [No Abstract]   [Full Text] [Related]  

  • 58. Position Statement from the German Biobank Alliance on the Cooperation Between Academic Biobanks and Industry Partners.
    Baber R; Hummel M; Jahns R; von Jagwitz-Biegnitz M; Kirsten R; Klingler C; Nussbeck SY; Specht C
    Biopreserv Biobank; 2019 Aug; 17(4):372-374. PubMed ID: 31314575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biospecimens and Biobanking in Global Health.
    Mendy M; Lawlor RT; van Kappel AL; Riegman PHJ; Betsou F; Cohen OD; Henderson MK
    Clin Lab Med; 2018 Mar; 38(1):183-207. PubMed ID: 29412882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifiability in biobanks: models, measures, and mitigation strategies.
    Malin B; Loukides G; Benitez K; Clayton EW
    Hum Genet; 2011 Sep; 130(3):383-92. PubMed ID: 21739176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.